HPB surgical devices market seen reaching $7.73 billion by 2030

The market for hepato-pancreatico-biliary surgical devices is projected to grow from $5.62 billion in 2025 to $7.73 billion by 2030, driven by robotic surgery, minimally invasive oncology procedures and better visualization tools. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Hepato-pancreatico-biliary surgical devices are used in complex liver, pancreas and bile duct procedures where precision and safety are critical. - The market’s projected rise signals stronger demand for advanced tools in specialized surgery, especially as hospitals expand minimally invasive and robotic capabilities.

What happened: - The Business Research Company released a report on the global hepato-pancreatico-biliary (HPB) surgeries surgical devices market. - The market is expected to grow from $5.62 billion in 2025 to $5.99 billion in 2026. - The report projects the market will reach $7.73 billion by 2030. - The forecast implies a compound annual growth rate of 6.6% from 2025 through 2030. - A free sample is available here. - The full report is available here.

The details: - HPB surgical devices include instruments for cutting, dissecting, grasping and suturing tissue during liver, pancreas and bile duct operations. - Market growth in the historical period was driven by rising liver and pancreatic disease rates, more specialized surgical centers, wider use of laparoscopic techniques, better access to advanced tools and stronger surgeon training. - The report says future growth will be supported by demand for robotic-assisted HPB surgeries, more investment in high-definition visualization technology, broader use of minimally invasive oncology procedures and a focus on precision and safety. - Key trends include advanced energy-based surgical devices, more minimally invasive techniques and greater use of robotic and visualization systems. - One growth driver is medical tourism, as patients travel abroad for advanced care, shorter wait times and lower-cost high-precision surgery. - U.S. Centers for Medicare and Medicaid Services data from December 2023 showed overall healthcare spending rose 4.1% to $4.5 trillion in 2023, while hospital care spending rose 2.2% to $1.4 trillion. - North America was the largest regional market in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook points to a shift toward more technologically sophisticated surgery, where robotic systems and high-definition imaging are becoming central to competitive advantage. - Medical tourism adds another layer of demand, because patients seeking specialized treatment can accelerate purchases of advanced surgical equipment in destination markets. - The report’s emphasis on market attractiveness scoring, TAM analysis and company scoring suggests vendors are likely to face stronger investor and procurement scrutiny.

What's next: - The market is expected to keep expanding through 2030 at a 6.6% annual rate. - Growth opportunities are likely to concentrate in robotic surgery, visualization technology and minimally invasive oncology workflows. - Asia-Pacific’s faster growth could reshape regional competition and purchasing priorities over the forecast period.

The bottom line: - HPB surgical devices are moving from niche specialty tools to a growing high-tech market, with demand set to expand steadily through the end of the decade.